Work

Phase I study of the safety and biological activity of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed ovarian cancer.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps5605

Authors: Premal H. Thaker, Charles A. Leath, William Hampton Bradley, Kathleen N. Moore, Nicholas Borys, Khursheed Anwer, Ronald David Alvarez

Institutions: Washington University in St. Louis, University of Alabama at Birmingham, Medical College of Wisconsin, University of Oklahoma Health Sciences Center, Celsion (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2794166407

Cites:

Cited by: 2

Related to: 10